Eledon Pharmaceuticals (ELDN)
3.78
+0.06 (1.61%)
Upcoming Events
Latest Headlines
Rodman & Renshaw Starts Eledon Pharamceuticals (ELDN) at Buy
July 21, 2026 6:31 AM - StreetInsider
NewcelX gets FDA feedback supporting NCEL-101 diabetes trial path
July 1, 2026 9:30 AM - StreetInsider
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
July 1, 2026 9:30 AM - StreetInsider
Natera and Eledon partner on kidney transplant Phase 3 trial
June 25, 2026 7:00 AM - StreetInsider
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026 7:00 AM - BizWire
Form 8-K Eledon Pharmaceuticals, For: Jun 18
June 22, 2026 5:00 PM - SEC Filing
Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
June 22, 2026 4:41 PM - StreetInsider
Eledon Pharamceuticals (ELDN) Reiterated at Overweight by Cantor Fitzgerald
June 22, 2026 7:35 AM - StreetInsider
Eledon reports Phase 2 kidney transplant drug data at ATC
June 22, 2026 7:00 AM - StreetInsider
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared wit
June 22, 2026 7:00 AM - StreetInsider
Eledon reports insulin independence in all 12 type 1 diabetes patients
June 8, 2026 7:02 AM - StreetInsider
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
June 8, 2026 7:00 AM - StreetInsider
Eledon to present islet transplant trial data at diabetes conference
June 4, 2026 4:31 PM - StreetInsider
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific
June 4, 2026 4:31 PM - Globe NewsWire
Eledon Pharmaceuticals to present kidney transplant study data at congress
May 20, 2026 4:05 PM - StreetInsider
Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
May 20, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: BIOTECHNOLOGY VALUE FUND L P
May 15, 2026 4:13 PM - SEC Filing
Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 15c
May 13, 2026 5:12 PM - StreetInsider
Form 10-Q Eledon Pharmaceuticals, For: Mar 31
May 13, 2026 4:21 PM - SEC Filing
Form 8-K Eledon Pharmaceuticals, For: May 13
May 13, 2026 4:15 PM - SEC Filing
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 13, 2026 4:05 PM - StreetInsider
Form EFFECT Eledon Pharmaceuticals,
May 12, 2026 6:07 AM - SEC Filing
Eledon Pharmaceuticals (ELDN) files $500M mixed shelf
May 1, 2026 4:11 PM - StreetInsider
Form S-3 Eledon Pharmaceuticals,
May 1, 2026 4:09 PM - SEC Filing
Form DEFA14A Eledon Pharmaceuticals,
April 30, 2026 5:07 PM - SEC Filing
Form ARS Eledon Pharmaceuticals, For: Dec 31
April 30, 2026 5:05 PM - SEC Filing
Form DEF 14A Eledon Pharmaceuticals, For: Jun 18
April 30, 2026 4:57 PM - SEC Filing
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
April 30, 2026 8:15 AM - Globe NewsWire
Form SCHEDULE 13G Eledon Pharmaceuticals, Filed by: BlackRock, Inc.
April 27, 2026 4:13 PM - SEC Filing
Full Article List
